ANIK insider transaction filings
Anika Therapeutics, Inc. — 37 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-05. Screen ANIK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Fischetti Gary P — Director | Purchase (P): 1,000 @ $20.75 · Purchase (P): 1,000 @ $20.32 | EDGAR |
| 2026-06-23 | 4 | Fischetti Gary P — Director | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-23 | 4 | Richard Stephen — Director | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-23 | 4 | Capper Joseph H — Director | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-23 | 4 | CONLEY SHERYL L — Director | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-23 | 4 | HENNEMAN JOHN B III — Director | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-05 | 4 | Griffin Stephen D. — President and CEO, Director | Option exercise (M): 12,840 · Tax withholding (F): 3,769 @ $14.41 · Option exercise (M): 12,840 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | HENNEMAN JOHN B III — Director | Purchase (P): 5,000 @ $14.66 | EDGAR |
| 2026-04-30 | 4 | Griffin Stephen D. — President and CEO, Director | Purchase (P): 12,200 @ $12.29 | EDGAR |
| 2026-03-23 | 4 | McLeod Ian — SVP, CAO & Treasurer | Grant/award (A): 13,097 (derivative) @ $0 · Grant/award (A): 11,194 (derivative) @ $0 · Grant/award (A): 17,663 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Griffin Stephen D. — President and CEO, Director | Option exercise (M): 12,824 · Grant/award (A): 6,412 @ $0 · Tax withholding (F): 5,944 @ $14.20 · Option exercise (M): 12,824 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Colleran David — EVP, General Counsel, Corp Sec | Option exercise (M): 9,388 · Grant/award (A): 4,694 @ $0 · Tax withholding (F): 4,168 @ $14.20 · Option exercise (M): 6,449 · Tax withholding (F): 1,893 @ $14.20 · Option exercise (M): 9,388 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-17 | 4 | McLeod Ian — SVP, CAO & Treasurer | Option exercise (M): 3,774 · Grant/award (A): 1,161 @ $0 · Tax withholding (F): 1,449 @ $14.20 · Option exercise (M): 2,658 · Tax withholding (F): 781 @ $14.20 · Option exercise (M): 3,774 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-17 | 4 | Blanchard Cheryl R — Director | Option exercise (M): 24,519 · Grant/award (A): 24,520 @ $0 · Tax withholding (F): 14,728 @ $14.20 · Option exercise (M): 25,131 · Tax withholding (F): 12,104 @ $14.20 · Option exercise (M): 24,519 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-11 | 4 | Colleran David — EVP, General Counsel, Corp Sec | Option exercise (M): 5,465 · Tax withholding (F): 1,919 @ $14.96 · Option exercise (M): 5,465 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | McLeod Ian — SVP, CAO & Treasurer | Option exercise (M): 2,197 · Tax withholding (F): 639 @ $14.96 · Option exercise (M): 2,197 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Blanchard Cheryl R — Director | Option exercise (M): 20,001 · Tax withholding (F): 5,871 @ $14.96 · Option exercise (M): 20,001 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Griffin Stephen D. — President and CEO, Director | Grant/award (A): 310,207 (derivative) @ $0 · Grant/award (A): 130,402 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Fischetti Gary P — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | Richard Stephen — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | Larsen Glenn R. — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | Capper Joseph H — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | CONLEY SHERYL L — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | VOGT SUSAN L N — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | Jellison William R — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-24 | 4 | HENNEMAN JOHN B III — Director | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-05 | 4 | Griffin Stephen D. — EVP, CFO & COO | Option exercise (M): 12,840 @ $0 · Tax withholding (F): 3,769 @ $11.59 · Option exercise (M): 12,840 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Nunes Anne — SVP, Chief Operations Officer | Option exercise (M): 3,637 @ $0 · Tax withholding (F): 1,068 @ $15.91 · Grant/award (A): 20,761 (derivative) @ $0 · Grant/award (A): 4,650 (derivative) @ $0 · Option exercise (M): 3,637 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Griffin Stephen D. — EVP, CFO and Treasurer | Grant/award (A): 38,473 (derivative) @ $0 · Grant/award (A): 18,672 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Colleran David — EVP, General Counsel, Corp Sec | Option exercise (M): 6,448 @ $0 · Tax withholding (F): 1,893 @ $15.91 · Grant/award (A): 28,165 (derivative) @ $0 · Grant/award (A): 13,669 (derivative) @ $0 · Option exercise (M): 6,448 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Blanchard Cheryl R — President, CEO, Director, Director | Option exercise (M): 25,132 @ $0 · Tax withholding (F): 12,152 @ $15.91 · Grant/award (A): 73,559 (derivative) @ $0 · Grant/award (A): 71,403 (derivative) @ $0 · Option exercise (M): 25,132 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Nunes Anne — SVP, Chief Operations Officer | Option exercise (M): 2,561 @ $0 · Tax withholding (F): 752 @ $16.79 · Option exercise (M): 2,561 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Colleran David — EVP, General Counsel, Corp Sec | Option exercise (M): 7,663 @ $0 · Tax withholding (F): 2,250 @ $16.79 · Option exercise (M): 7,663 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Blanchard Cheryl R — President, CEO, Director, Director | Option exercise (M): 30,060 @ $0 · Tax withholding (F): 12,675 @ $16.79 · Option exercise (M): 30,060 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Nunes Anne — SVP, Chief Operations Officer | Option exercise (M): 3,296 @ $0 · Tax withholding (F): 959 @ $16.62 · Option exercise (M): 3,296 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Colleran David — EVP, General Counsel, Corp Sec | Option exercise (M): 5,465 @ $0 · Tax withholding (F): 1,604 @ $16.62 · Option exercise (M): 5,465 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Blanchard Cheryl R — President, CEO, Director, Director | Option exercise (M): 20,002 @ $0 · Tax withholding (F): 5,871 @ $16.62 · Option exercise (M): 20,002 (derivative) @ $0 | EDGAR |
Recent 8-K events — Anika Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANIK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →